⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 23, 2014American Journal of Roentgenology

Prognostic Value of FDG PET Metabolic Tumor Volume in Human Papillomavirus–Positive Stage III and IV Oropharyngeal Squamous Cell Carcinoma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Total MTV and primary-tumor MTV are associated with survival outcomes in patients with HPV-positive stage III and IV oropharyngeal SCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alluri et al. (2014) studied this question.

synapsesocial.com/papers/69da23cea6045d71bfa3c135 https://doi.org/10.2214/ajr.14.12497

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx CarcinomaPrognostic Study · 2003 · 902 citations
2Prognostic Value of 18F-FDG PET in Patients with Head and Neck Squamous Cell CancerPrognostic Study · 2009 · 87 citations
3Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United StatesOriginal Research · 2008 · 1,592 citations
4Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialCohort Study · 2008 · 2,818 citations